Browsing: Gilead

[ad_1] Sundry Images/iStock Editorial through Getty Photographs Gilead Sciences (NASDAQ:GILD) has accomplished its $4.3B acquisition of CymaBay Therapeutics (NASDAQ:CBAY). Nonetheless,…

[ad_1] jurgenfr Gilead Sciences (NASDAQ:GILD) is predicted to report the next This autumn revenue on decrease income Tuesday night, with…

[ad_1] Sundry Images Arcus Biosciences (NYSE:RCUS) shares jumped 16% in post-market buying and selling Monday following information that accomplice Gilead…